Q2 2026 saw a 9.8% year-over-year revenue decline to $2.825 billion, driven by hospital divestitures, while same-store revenues rose 2.4%. Net income attributable to stockholders dropped to $70 million, with ongoing regulatory and Medicaid funding risks expected to pressure future results.

Original document:

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.